Compared to those receiving the placebo, patients receiving cannabis extracts demonstrated significant improvements in pain intensity, sleep quality, physical function, and overall quality of life.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“Approximately one in five older Canadians reported using cannabis, at least in part, to manage mental health symptoms,” investigators reported.
The study’s authors cautioned against relying on ocular measures as evidence of cannabis-induced impairment, suggesting that the tests lacked the accuracy and specificity necessary to be a valid evidentiary tool.
“THC enhances memory, reduces inflammation, and offers neuroprotection, while CBD extends lifespan, improves motility, and promotes autophagy in preclinical models,” researchers reported.
“Alcohol and cigarette smoking rather than the use of cannabis may play a major role in establishing an association between cannabis use and head and neck cancers,” investigators determined.
In total, fewer than ten percent of all financial institutions nationwide provide services to state-licensed cannabis businesses.
Participants who consumed CBD-dominant products experienced the greatest decrease in symptoms.
Among EB patients who consume cannabis, 28 percent report that cannabinoids provide greater pain relief than traditional medications.